SI2596800T1 - Uporaba inzulina glargina za zniževanje ali preprečevanje kardiovaskularne obolevnosti in umrljivosti pri prediabetičnih pacientih - Google Patents

Uporaba inzulina glargina za zniževanje ali preprečevanje kardiovaskularne obolevnosti in umrljivosti pri prediabetičnih pacientih

Info

Publication number
SI2596800T1
SI2596800T1 SI200432361A SI200432361A SI2596800T1 SI 2596800 T1 SI2596800 T1 SI 2596800T1 SI 200432361 A SI200432361 A SI 200432361A SI 200432361 A SI200432361 A SI 200432361A SI 2596800 T1 SI2596800 T1 SI 2596800T1
Authority
SI
Slovenia
Prior art keywords
mortality
reduce
insulin glargine
diabetes patients
prevent cardiovascular
Prior art date
Application number
SI200432361A
Other languages
English (en)
Inventor
Ralf Rosskamp
Hertzel Gerstein
Original Assignee
Aventisub Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventisub Llc filed Critical Aventisub Llc
Publication of SI2596800T1 publication Critical patent/SI2596800T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200432361A 2003-01-14 2004-01-14 Uporaba inzulina glargina za zniževanje ali preprečevanje kardiovaskularne obolevnosti in umrljivosti pri prediabetičnih pacientih SI2596800T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43994103P 2003-01-14 2003-01-14
EP13155801.7A EP2596800B1 (en) 2003-01-14 2004-01-14 Use of insulin glargine to reduce or prevent cardiovascular morbidity and mortality in pre-diabetes patients

Publications (1)

Publication Number Publication Date
SI2596800T1 true SI2596800T1 (sl) 2017-04-26

Family

ID=23746761

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200432361A SI2596800T1 (sl) 2003-01-14 2004-01-14 Uporaba inzulina glargina za zniževanje ali preprečevanje kardiovaskularne obolevnosti in umrljivosti pri prediabetičnih pacientih

Country Status (16)

Country Link
US (4) US7405196B2 (sl)
EP (2) EP1589991A1 (sl)
JP (1) JP5389325B2 (sl)
AU (2) AU2004206829B2 (sl)
BR (1) BRPI0406499A (sl)
CA (1) CA2512820C (sl)
CY (1) CY1118738T1 (sl)
DK (1) DK2596800T3 (sl)
ES (1) ES2604359T3 (sl)
GB (1) GB0309154D0 (sl)
HU (1) HUE031892T2 (sl)
IL (3) IL169697A (sl)
MX (1) MXPA05007470A (sl)
PT (1) PT2596800T (sl)
SI (1) SI2596800T1 (sl)
WO (1) WO2004064862A1 (sl)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
ATE385193T1 (de) 2002-03-20 2008-02-15 Mannkind Corp Inhalationsgerät
ES2328579T3 (es) * 2003-07-25 2009-11-16 Conjuchem Biotechnologies Inc. Derivados de insulina de larga duracion y procedimientos asociados.
AU2005277208B2 (en) 2004-08-20 2011-11-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
DK1791542T3 (en) 2004-08-23 2015-06-15 Mannkind Corp Diketopiperazinsalte for pharmaceutical delivery
BRPI0615819B8 (pt) 2005-09-14 2021-05-25 Mannkind Corp processo para preparar uma composição de distribuição de fármaco compreendendo um agente ativo e uma micropartícula fumaril dicetopiperazina cristalina.
CN101389348A (zh) 2006-02-22 2009-03-18 曼金德公司 用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法
CA3086027C (en) 2008-06-13 2022-05-17 Mannkind Corporation A dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
MX2010014240A (es) 2008-06-20 2011-03-25 Mankind Corp Un metodo y aparato interactivo para perfilar en tiempo real esfuerzos de inhalacion.
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
CA3016451A1 (en) 2008-10-17 2010-04-22 Sanofi-Aventis Deutschland Gmbh Combination of an insulin and a glp-1 agonist
US9117015B2 (en) 2008-12-23 2015-08-25 Roche Diagnostics Operations, Inc. Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
US20120011125A1 (en) 2008-12-23 2012-01-12 Roche Diagnostics Operations, Inc. Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
US10437962B2 (en) 2008-12-23 2019-10-08 Roche Diabetes Care Inc Status reporting of a structured collection procedure
US9659037B2 (en) 2008-12-23 2017-05-23 Roche Diabetes Care, Inc. Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
US9918635B2 (en) 2008-12-23 2018-03-20 Roche Diabetes Care, Inc. Systems and methods for optimizing insulin dosage
US10456036B2 (en) 2008-12-23 2019-10-29 Roche Diabetes Care, Inc. Structured tailoring
US8849458B2 (en) * 2008-12-23 2014-09-30 Roche Diagnostics Operations, Inc. Collection device with selective display of test results, method and computer program product thereof
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
DK2405963T3 (da) 2009-03-11 2013-12-16 Mannkind Corp Apparat, system og fremgangsmåde til at måle modstand i en inhalator
WO2010144789A2 (en) 2009-06-12 2010-12-16 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
WO2011056889A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
KR101772372B1 (ko) 2009-11-13 2017-08-29 사노피-아벤티스 도이칠란트 게엠베하 Ｇｌｐ-1 효능제 및 메티오닌을 포함하는 약제학적 조성물
RU2537239C2 (ru) 2009-11-13 2014-12-27 Санофи-Авентис Дойчланд Гмбх Фармацевтическая композиция, включающая агонист glp-1, инсулин и метионин
AU2011202239C1 (en) 2010-05-19 2017-03-16 Sanofi Long-acting formulations of insulins
US8532933B2 (en) 2010-06-18 2013-09-10 Roche Diagnostics Operations, Inc. Insulin optimization systems and testing methods with adjusted exit criterion accounting for system noise associated with biomarkers
KR20130117755A (ko) 2010-06-21 2013-10-28 맨카인드 코포레이션 건조 분말 약물 운반 시스템 및 방법
HUE031181T2 (en) 2010-08-30 2017-06-28 Sanofi Aventis Deutschland Use of AVE0010 for the manufacture of a medicament for the treatment of type 2 diabetes
US20120173151A1 (en) 2010-12-29 2012-07-05 Roche Diagnostics Operations, Inc. Methods of assessing diabetes treatment protocols based on protocol complexity levels and patient proficiency levels
WO2012135765A2 (en) 2011-04-01 2012-10-04 Mannkind Corporation Blister package for pharmaceutical cartridges
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
US8755938B2 (en) 2011-05-13 2014-06-17 Roche Diagnostics Operations, Inc. Systems and methods for handling unacceptable values in structured collection protocols
US8766803B2 (en) 2011-05-13 2014-07-01 Roche Diagnostics Operations, Inc. Dynamic data collection
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
SI2750699T1 (sl) 2011-08-29 2015-11-30 Sanofi-Aventis Deutschland Gmbh Farmacevtska kombinacija, za uporabo pri glikemični kontroli pri pacientih, ki imajo sladkorno bolezen tipa 2
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
MX2014004983A (es) 2011-10-24 2014-09-22 Mannkid Corp Metodos y composiciones para tratar dolor.
EP2785366A1 (en) * 2011-12-01 2014-10-08 Sanofi Insulin glargine versus metformin for the first-line treatment of early type 2 diabetes
MX2014011687A (es) * 2012-03-28 2015-05-11 Sanofi Sa Tratamiento con insulina basal.
CN104619369B (zh) 2012-07-12 2018-01-30 曼金德公司 干粉药物输送系统和方法
EP2911690A1 (en) 2012-10-26 2015-09-02 MannKind Corporation Inhalable influenza vaccine compositions and methods
WO2014144895A1 (en) 2013-03-15 2014-09-18 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
JP6457484B2 (ja) 2013-04-03 2019-01-23 サノフイＳａｎｏｆｉ インスリンの長時間作用型製剤による糖尿病の治療
JP6491658B2 (ja) 2013-07-18 2019-03-27 マンカインド コーポレイション 熱安定性乾燥粉末医薬組成物及び方法
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
WO2016001185A1 (en) * 2014-07-02 2016-01-07 Novo Nordisk A/S Dosage regimen for the treatment of diabetes
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
HRP20230470T1 (hr) 2014-12-12 2023-07-21 Sanofi-Aventis Deutschland Gmbh Formulacija fiksnog omjera inzulin glargin/liksisenatid
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
WO2017108943A1 (en) * 2015-12-23 2017-06-29 Sanofi-Aventis Deutschland Gmbh Cardiac metabolic effect of lantus
WO2018096164A1 (en) * 2016-11-28 2018-05-31 Novo Nordisk A/S Insulin degludec for treating diabetes
EP3544683A1 (en) 2016-11-28 2019-10-02 Novo Nordisk A/S Insulin degludec in cardiovascular conditions
WO2018096163A1 (en) * 2016-11-28 2018-05-31 Novo Nordisk A/S Insulin degludec for improvement of glycaemic control and reduction of acute and long-term diabetes complications
US11366189B2 (en) * 2020-09-25 2022-06-21 Uih America, Inc. Systems and methods for magnetic resonance imaging

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354331A (en) 1992-07-15 1994-10-11 Schachar Ronald A Treatment of presbyopia and other eye disorders
US6242474B1 (en) * 1997-06-27 2001-06-05 Fujisawa Pharmaceutical Co., Ltd. Aromatic ring derivatives
CO5271699A1 (es) * 2000-01-24 2003-04-30 Pfizer Prod Inc Procedimiento para el tratamiento de cardiomiopatia utilizando inhibidores de la glucogeno fosforilasa
US20040009961A1 (en) * 2000-04-19 2004-01-15 Borody Thomas Julius Composition and therapies for hyperlipidaemia-associated disorders
PT1328266E (pt) * 2000-10-26 2006-05-31 Fournier Lab Ireland Ltd Combinacao de fenofibrato e coenzima q10 para o tratamento de disfuncao endotelial

Also Published As

Publication number Publication date
PT2596800T (pt) 2016-12-02
US20080287343A1 (en) 2008-11-20
DK2596800T3 (en) 2016-12-12
AU2004206829A1 (en) 2004-08-05
IL169697A (en) 2011-06-30
US7405196B2 (en) 2008-07-29
AU2010202738A1 (en) 2010-07-22
MXPA05007470A (es) 2005-09-21
IL169697A0 (en) 2007-07-04
US20130012433A1 (en) 2013-01-10
AU2004206829B2 (en) 2010-04-08
IL197739A (en) 2017-02-28
ES2604359T3 (es) 2017-03-06
GB0309154D0 (en) 2003-05-28
WO2004064862A1 (en) 2004-08-05
BRPI0406499A (pt) 2005-12-06
EP2596800A1 (en) 2013-05-29
AU2010202738B2 (en) 2013-12-05
IL208525A0 (en) 2010-12-30
US8809270B2 (en) 2014-08-19
JP2006515625A (ja) 2006-06-01
US20110281793A1 (en) 2011-11-17
JP5389325B2 (ja) 2014-01-15
IL197739A0 (en) 2011-08-01
EP1589991A1 (en) 2005-11-02
US20040229774A1 (en) 2004-11-18
EP2596800B1 (en) 2016-08-24
US7977310B2 (en) 2011-07-12
CA2512820A1 (en) 2004-08-05
CY1118738T1 (el) 2017-07-12
HUE031892T2 (en) 2017-08-28
CA2512820C (en) 2013-06-04

Similar Documents

Publication Publication Date Title
SI2596800T1 (sl) Uporaba inzulina glargina za zniževanje ali preprečevanje kardiovaskularne obolevnosti in umrljivosti pri prediabetičnih pacientih
NO2018003I1 (no) Combination of insulin degludec and insulin aspart
IL171501A (en) Genetically engineered cutaneous microorganisms and their use
HUP0203367A3 (en) Benzylidine-thiazolidinediones and analogues and their use in the treatment of diabetes
IL163278A (en) Formulations including glp-1 compounds and their use in drug preparation
HUP0500982A2 (en) Improvements in and relating to medicament injection apparatus
GB0212551D0 (en) Improvements in and relating to optical devices
IL180650A0 (en) Infusion and injection solution of levodopa
EP1586332A4 (en) COMBINED USE OF CARNOSINAS INHIBITOR WITH L-CARNOSINES AND COMPOSITION
ZA200610786B (en) Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes and related conditions
GB0205559D0 (en) Improvements in and relating to the filling of explosive ordnance
AU2003207824A8 (en) K-type polarizer and preparation thereof
TW526785U (en) Structure of toy with compressible packaging and storage space
EP1691779A4 (en) TREATMENT OF A STATE IN A MAMMALIAN WITH THE ADMINISTRATION OF COMPOUNDS AND APPLICATION METHOD THEREFOR
GB0324965D0 (en) Improvements in and relating to pumps
GB0207596D0 (en) Improvements in or relating to patient support structures and their use
GB2400225B (en) Improvements in and relating to display devices
GB2408468B (en) Improvements in and relating to pumps
GB2395832B (en) Improvements in and relating to display devices
TW551100U (en) Structure of display body easy in storing article
TW583934U (en) Improved structure of leg easy in positioning and assembly
TW579771U (en) Massage chair with leg portion connected to body portion and with improved structure
GB0311282D0 (en) Improvements in and relating to pumping
GB0228951D0 (en) Improvements in and relating to medicine packs
GB0227123D0 (en) Improvements in and relating to ladders